Filing Details
- Accession Number:
- 0001140361-17-003548
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-30 21:36:37
- Reporting Period:
- 2017-01-26
- Filing Date:
- 2017-01-30
- Accepted Time:
- 2017-01-30 21:36:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1301501 | Achaogen Inc | AKAO | Pharmaceutical Preparations (2834) | 680533693 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1616014 | Ian Friedland | C/O Achaogen, Inc. 7000 Shoreline Court, #371 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-01-26 | 695 | $16.78 | 38,033 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer.
- Includes 23,150 Restricted Stock Units and an aggregate of 6,000 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2016 and November 30, 2016.